BusinessARCA Biopharma Announces Issuance of European Patent for Treating Cardiovascular Diseases and Conditions With a New Chemical Entity Utilizing Genetic TargetingBy Nasdaq OMXNov 16, 2017, 1:30 PM UTC
BusinessEarth Science Tech, Inc. Announces Partnership with Bionatus to Help Manufacture, Distribute, & Continue Further R&D on Cannabis (CBD) ProductsBy Nasdaq OMXAug 22, 2017, 12:25 PM UTC
BusinessARCA biopharma Announces Completion of Enrollment for GENETIC-AF Phase 2B Clinical TrialBy Nasdaq OMXAug 16, 2017, 12:30 PM UTC
BusinessARCA biopharma Announces GENETIC-AF Data and Safety Monitoring Board Recommendation to Complete Phase 2B GENETIC-AF Clinical Trial Based on Efficacy and Safety Data in Phase 2B Interim AnalysisBy Nasdaq OMXAug 9, 2017, 8:30 PM UTC
BusinessARCA biopharma Announces Second Quarter 2017 Financial Results and Provides Business UpdateBy Nasdaq OMXAug 3, 2017, 8:15 PM UTC
BusinessARCA Biopharma Announces Database Lock for GENETIC-AF Phase 2B Interim Efficacy Analysis – DSMB Recommendation Anticipated in August 2017By Nasdaq OMXJun 20, 2017, 12:30 PM UTC
BusinessASE 28th Annual Scientific Sessions Feature Innovative Learning Opportunities, a Value of Echo Summit, and Cutting-Edge ResearchBy Nasdaq OMXMay 16, 2017, 12:02 PM UTC
BusinessASE 28th Annual Scientific Sessions Feature Innovative Learning Opportunities, a Value of Echo Summit, and Cutting-Edge ResearchBy Nasdaq OMXMay 16, 2017, 12:02 PM UTC
